|  Help  |  About  |  Contact Us

Publication : Biology of presenilins as causative molecules for Alzheimer disease.

First Author  Nishimura M Year  1999
Journal  Clin Genet Volume  55
Issue  4 Pages  219-25
PubMed ID  10361981 Mgi Jnum  J:54558
Mgi Id  MGI:1336487 Doi  10.1034/j.1399-0004.1999.550401.x
Citation  Nishimura M, et al. (1999) Biology of presenilins as causative molecules for Alzheimer disease. Clin Genet 55(4):219-25
abstractText  Many missense mutations in the presenilins are associated with autosomal dominant forms of familial Alzheimer disease (AD). Presenilin genes encode polytopic transmembrane proteins, which are processed by proteolytic cleavage and form high-molecular-weight complexes under physiological conditions. The presenilins have been suggested to be functionally involved in developmental morphogenesis, apoptosis signal pathways, and processing of selected proteins including beta-amyloid precursor protein. Although the underlying mechanism in which presenilin mutations lead to development of AD remains elusive, one consistent mutational effect is an overproduction of long-tailed amyloid beta-peptides. Furthermore, presenilins interact with beta-catenin to form presenilin complexes and presenilin mutations effect beta-catenin signalling pathways.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

Trail: Publication

0 Expression